Director/PDMR Shareholding
30 December 2022 11:00 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announces that, on 29 December 2022, it was notified by Pascal Soriot, Chief Executive Officer, that, on 23 December 2022, Mr Soriot ceased to be beneficially interested in 163,838 Ordinary Shares of $0.25 each in the Company, following the gift of those shares to family members for nil consideration. Further details are set out in the attached notification, made in accordance with the requirements of the EU Market Abuse Regulation (as it forms part of UK law